{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:43:39Z","timestamp":1776815019555,"version":"3.51.2"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Brazilian National Council for Scientific and Technological Development"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13083-2","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:47:30Z","timestamp":1773420450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalence, immune response dynamics, and incidence of COVID-19 after CoronaVac vaccination in a fully vaccinated small municipality in Northeast Brazil: a population-based surveillance study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6334-8624","authenticated-orcid":false,"given":"Lourrany Borges","family":"Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9767-7154","authenticated-orcid":false,"given":"Francisca Kalline de Almeida","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2863-0787","authenticated-orcid":false,"given":"Patr\u00edcia Pereira Lima","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4806-2345","authenticated-orcid":false,"given":"Magda Moura de","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6861-183X","authenticated-orcid":false,"given":"Antonia Luciana Souza","family":"Bekman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9603-9187","authenticated-orcid":false,"given":"Silvana Soares de","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9927-4631","authenticated-orcid":false,"given":"Ana Carolina Barjud Marques","family":"M\u00e1ximo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5642-7749","authenticated-orcid":false,"given":"Debora Bezerra","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2967-532X","authenticated-orcid":false,"given":"Carlos Henrique","family":"Alencar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3440-1182","authenticated-orcid":false,"given":"Luciano Pamplona de G\u00f3es","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"3","key":"13083_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cmi.2020.10.020","volume":"27","author":"A Rostami","year":"2021","unstructured":"Rostami A, Sepidarkish M, Leeflang MMG, Riahi SM, Nourollahpour Shiadeh M, Esfandyari S, et al. SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis. Clin Microbiol Infect. 2021;27(3):331\u201340. https:\/\/doi.org\/10.1016\/j.cmi.2020.10.020.","journal-title":"Clin Microbiol Infect"},{"key":"13083_CR2","unstructured":"World Health Organization. WHO Director-General\u2019s opening remarks at the media briefing on COVID-19\u201311 March 2020. Geneva: WHO. 2020. Available from: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020."},{"issue":"10273","key":"13083_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0140-6736(21)00183-5","volume":"397","author":"EC Sabino","year":"2021","unstructured":"Sabino EC, Buss LF, Carvalho MP, Prete CA Jr, Crispim MAE, Fraiji NA, et al. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. Lancet. 2021;397(10273):452\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(21)00183-5.","journal-title":"Lancet"},{"issue":"6544","key":"13083_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1126\/science.abh2644","volume":"372","author":"NR Faria","year":"2021","unstructured":"Faria NR, Mellan TA, Whittaker C, Claro IM, Candido DDS, Mishra S, et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science. 2021;372(6544):815\u201321. https:\/\/doi.org\/10.1126\/science.abh2644.","journal-title":"Science"},{"key":"13083_CR5","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Painel COVID-19: casos e \u00f3bitos. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2025. Available from: https:\/\/infoms.saude.gov.br\/extensions\/covid-19_html\/covid-19_html.html."},{"key":"13083_CR6","doi-asserted-by":"publisher","unstructured":"Azevedo e, Silva G, Jardim BC, dos Brito CV. Excess mortality in Brazil in times of COVID-19. Ci\u00eancia & Sa\u00fade Coletiva. 2020;25(9):3345\u20133354. https:\/\/doi.org\/10.1590\/1413-81232020259.23642020.","DOI":"10.1590\/1413-81232020259.23642020"},{"issue":"3","key":"13083_CR7","doi-asserted-by":"publisher","first-page":"e0319941","DOI":"10.1371\/journal.pone.0319941","volume":"20","author":"CV Brito dos Santos","year":"2025","unstructured":"Brito dos Santos CV, Coelho LE, Goedert GT, Luz PM, Werneck GL, Villela DAM, Struchiner CJ. Disability-adjusted life years associated with COVID-19 in Brazil, 2020. PLoS ONE. 2025;20(3):e0319941. https:\/\/doi.org\/10.1371\/journal.pone.0319941.","journal-title":"PLoS ONE"},{"key":"13083_CR8","doi-asserted-by":"publisher","first-page":"100465","DOI":"10.1016\/j.lana.2023.100465","volume":"20","author":"CB Santos","year":"2023","unstructured":"Santos CB, et al. The effectiveness of COVID-19 vaccines against severe cases and deaths in Brazil from 2021 to 2022. Lancet Reg Health - Americas. 2023;20:100465. https:\/\/doi.org\/10.1016\/j.lana.2023.100465.","journal-title":"Lancet Reg Health - Americas"},{"issue":"7","key":"13083_CR9","doi-asserted-by":"publisher","first-page":"e044600","DOI":"10.1136\/bmjopen-2020-044600","volume":"11","author":"JY Islam","year":"2021","unstructured":"Islam JY, Vidot DC, Camacho-Rivera M. Determinants of COVID-19 preventive behaviours among adults with chronic diseases in the USA: analysis of the nationally representative COVID-19 Impact Survey. BMJ Open. 2021;11(7):e044600. https:\/\/doi.org\/10.1136\/bmjopen-2020-044600.","journal-title":"BMJ Open"},{"key":"13083_CR10","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1038\/s41467-022-30895-3","volume":"13","author":"H Chemaitelly","year":"2022","unstructured":"Chemaitelly H, Ayoub HH, AlMukdad S, Coyle P, Tang P, Yassine HM, et al. Duration of mRNA vaccine protection against Omicron BA.1\/BA.2 subvariants in Qatar. Nat Commun. 2022;13:3082. https:\/\/doi.org\/10.1038\/s41467-022-30895-3.","journal-title":"Nat Commun"},{"issue":"16","key":"13083_CR11","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, et al. Covid-19 vaccine effectiveness against the Omicron variant. N Engl J Med. 2022;386(16):1532\u201346. https:\/\/doi.org\/10.1056\/NEJMoa2119451.","journal-title":"N Engl J Med"},{"key":"13083_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10935-022-00719-7","volume":"44","author":"E Wachira","year":"2023","unstructured":"Wachira E, Khalid I, Osman A, Ngugi B. Factors influencing COVID-19 prevention behaviors. J Prim Prev. 2023;44:35\u201352. https:\/\/doi.org\/10.1007\/s10935-022-00719-7.","journal-title":"J Prim Prev"},{"issue":"9","key":"13083_CR13","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1590\/1413-81232020259.25532020","volume":"25","author":"PC Hallal","year":"2020","unstructured":"Hallal PC, et al. EPICOVID19 protocol: repeated serological surveys on SARS-CoV-2 antibodies in Brazil. Ci\u00eanc sa\u00fade coletiva. 2020;25(9):3573\u20138. https:\/\/doi.org\/10.1590\/1413-81232020259.25532020.","journal-title":"Ci\u00eanc sa\u00fade coletiva"},{"issue":"Supplement1","key":"13083_CR14","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/ije\/dyaf153","volume":"55","author":"CV Brito dos Santos","year":"2026","unstructured":"Brito dos Santos CV, et al. History of self-reported COVID-19 cases and hospitalizations in the Brazilian population: a countrywide survey. Int J Epidemiol. 2026;55(Supplement1):i1\u201312. https:\/\/doi.org\/10.1093\/ije\/dyaf153.","journal-title":"Int J Epidemiol"},{"issue":"Suppl 1","key":"13083_CR15","doi-asserted-by":"publisher","first-page":"10s","DOI":"10.1016\/j.clinsp.2023.100233","volume":"57","author":"AM Figueiredo","year":"2023","unstructured":"Figueiredo AM, Moreira RS, de Paula LGN, et al. Seroprevalence of SARS-CoV-2 in Brazilian population-based surveys, 2020\u20132021: a systematic review and meta-analysis. Rev Saude Publica. 2023;57(Suppl 1):10s. https:\/\/doi.org\/10.1016\/j.clinsp.2023.100233.","journal-title":"Rev Saude Publica"},{"key":"13083_CR16","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Brasil inicia vacina\u00e7\u00e3o contra a COVID-19 com a CoronaVac. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2021. Available from: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/noticias\/brasil-inicia-vacinacao-contra-a-covid-19."},{"key":"13083_CR17","unstructured":"de Ag\u00eancia N. Vigil\u00e2ncia Sanit\u00e1ria (ANVISA). CoronaVac \u2013 vacina adsorvida COVID-19 (inativada). Bras\u00edlia (DF): ANVISA; 2021. Available from: https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/campanhas\/coronavirus\/vacinas\/coronavac."},{"key":"13083_CR18","doi-asserted-by":"publisher","first-page":"e210009","DOI":"10.1590\/1980-549720210009","volume":"24","author":"DC Malta","year":"2021","unstructured":"Malta DC, Szwarcwald CL, Barros MBA, et al. Doen\u00e7as cr\u00f4nicas n\u00e3o transmiss\u00edveis e mudan\u00e7as nos estilos de vida durante a pandemia de COVID-19 no Brasil. Rev Bras Epidemiol. 2021;24:e210009. https:\/\/doi.org\/10.1590\/1980-549720210009.","journal-title":"Rev Bras Epidemiol"},{"issue":"Suppl 3","key":"13083_CR19","doi-asserted-by":"publisher","first-page":"e00196120","DOI":"10.1590\/0102-311X00196120","volume":"36","author":"SR Batista","year":"2020","unstructured":"Batista SR, Silva AS, Raulino JF, et al. Comportamentos de prote\u00e7\u00e3o contra COVID-19 entre adultos e idosos brasileiros com multimorbidade: ELSI-COVID-19. Cad Saude Publica. 2020;36(Suppl 3):e00196120. https:\/\/doi.org\/10.1590\/0102-311X00196120.","journal-title":"Cad Saude Publica"},{"key":"13083_CR20","doi-asserted-by":"publisher","first-page":"e20200354","DOI":"10.1590\/0037-8682-0354-2020","volume":"53","author":"DRQ Lemos","year":"2020","unstructured":"Lemos DRQ, D\u2019Angelo SM, Farias LABG, et al. Health system collapse after detection of COVID-19 in Cear\u00e1, Brazil: preliminary analysis. Rev Soc Bras Med Trop. 2020;53:e20200354. https:\/\/doi.org\/10.1590\/0037-8682-0354-2020.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"11","key":"13083_CR21","doi-asserted-by":"publisher","first-page":"e1390","DOI":"10.1016\/S2214-109X(20)30387-9","volume":"8","author":"PC Hallal","year":"2020","unstructured":"Hallal PC, Hartwig FP, Horta BL, et al. SARS-CoV-2 antibody prevalence in Brazil: results from nationwide serological surveys. Lancet Glob Health. 2020;8(11):e1390\u20138. https:\/\/doi.org\/10.1016\/S2214-109X(20)30387-9.","journal-title":"Lancet Glob Health"},{"key":"13083_CR22","unstructured":"Prefeitura de Guaramiranga. Contra o coronav\u00edrus (COVID-19). 2025. Available from: https:\/\/www.guaramiranga.ce.gov.br\/campanha.php?pg=COVID-19."},{"key":"13083_CR23","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1590\/s1678-9946202567050","volume":"67","author":"LB Costa","year":"2025","unstructured":"Costa LB, et al. Clinical, epidemiological, and laboratory analysis of hospitalized and fatal COVID-19 cases in the first fully vaccinated municipality in Northeast Brazil. Rev Inst Med Trop Sao Paulo. 2025;67:e50. https:\/\/doi.org\/10.1590\/s1678-9946202567050.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"99","key":"13083_CR24","doi-asserted-by":"publisher","first-page":"16992","DOI":"10.36489\/saudecoletiva.2025v16i99p16992-17013","volume":"15","author":"LB Costa","year":"2025","unstructured":"Costa LB, et al. Preventive behavior and factors associated with COVID-19 in fully vaccinated adults. Saude Colet (Ed Bras). 2025;15(99):16992\u20137013. https:\/\/doi.org\/10.36489\/saudecoletiva.2025v16i99p16992-17013.","journal-title":"Saude Colet (Ed Bras)"},{"key":"13083_CR25","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE). Cidades e Estados: Guaramiranga. Bras\u00edlia (DF): IBGE. 2024. Available from: https:\/\/cidades.ibge.gov.br\/brasil\/ce\/guaramiranga\/panorama."},{"key":"13083_CR26","unstructured":"Secretaria da Sa\u00fade do Cear\u00e1. Primeira cidade do Cear\u00e1 a vacinar 100% dos adultos, Guaramiranga ter\u00e1 popula\u00e7\u00e3o monitorada pela Sesa [Internet]. Fortaleza (CE): Secretaria da Sa\u00fade do Cear\u00e1; 27 jun 2021 [cited 2026 Feb 7]. Available from: https:\/\/www.saude.ce.gov.br\/2021\/06\/27\/primeira-cidade-do-ceara-a-vacinar-100-dos-adultos-guaramiranga-tera-populacao-monitorada-pela-sesa\/."},{"key":"13083_CR27","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Guia de Vigil\u00e2ncia Epidemiol\u00f3gica: COVID-19. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2021. Available from: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/saude-de-a-a-z\/c\/covid-19\/publicacoes-tecnicas\/guias-e-planos\/guia-de-vigilancia-epidemiologica-covid-19\/view."},{"key":"13083_CR28","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Plano Nacional de Operacionaliza\u00e7\u00e3o da Vacina\u00e7\u00e3o contra a COVID-19. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade. 2021. Available from: https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/saude-de-a-a-z\/c\/covid-19\/publicacoes-tecnicas\/guias-e-planos\/plano-nacional-de-operacionalizacao-da-vacinacao-contra-covid-19.pdf\/view."},{"key":"13083_CR29","unstructured":"Centers for Disease Control and Prevention (CDC). Interim guidelines for collecting and handling clinical specimens for COVID-19. Atlanta. 2020. Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/guidelines-clinical-specimens.html."},{"key":"13083_CR30","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA). Boletim T\u00e9cnico BM-BUL-136-02-R: Kit Molecular SARS-CoV-2 (E\/RP) [Internet]. Bras\u00edlia (DF): ANVISA, [cited 2026 Feb 7]. Available at: https:\/\/consultas.anvisa.gov.br\/api\/consulta\/produtos\/25351298372202069\/anexo\/T16315739\/nomeArquivo\/BM-BUL-136-02-R.pdf."},{"key":"13083_CR31","unstructured":"Abbott Laboratories. AdviseDx SARS-CoV-2 IgG II \u2014 Instructions for Use. Abbott Park, IL, USA. 2021. Available at: https:\/\/www.fda.gov\/media\/146372\/download."},{"key":"13083_CR32","unstructured":"Minist\u00e9rio da Sa\u00fade (Brasil). Notifica [Internet]. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; [cited 2026 Feb 7]. Available from: https:\/\/notifica.saude.gov.br\/login."},{"issue":"6587","key":"13083_CR33","doi-asserted-by":"publisher","first-page":"eabm0811","DOI":"10.1126\/science.abm0811","volume":"375","author":"CJ Reynolds","year":"2022","unstructured":"Reynolds CJ, Gibbons JM, Pade C, et al. Heterologous infection and vaccination shape immunity against SARS-CoV-2 variants. Science. 2022;375(6587):eabm0811. https:\/\/doi.org\/10.1126\/science.abm0811.","journal-title":"Science"},{"key":"13083_CR34","doi-asserted-by":"publisher","first-page":"n2015","DOI":"10.1136\/bmj.n2015","volume":"374","author":"OT Ranzani","year":"2021","unstructured":"Ranzani OT, Hitchings MDT, Dorion M, et al. Effectiveness of CoronaVac during a Gamma variant epidemic in Brazil: test-negative case-control study. BMJ. 2021;374:n2015. https:\/\/doi.org\/10.1136\/bmj.n2015.","journal-title":"BMJ"},{"issue":"10","key":"13083_CR35","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa2107715","volume":"385","author":"A Jara","year":"2021","unstructured":"Jara A, Undurraga EA, Gonz\u00e1lez C, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N Engl J Med. 2021;385(10):875\u201384. https:\/\/doi.org\/10.1056\/NEJMoa2107715.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"13083_CR36","doi-asserted-by":"publisher","first-page":"6s","DOI":"10.11606\/s1518-8787.2023057004782","volume":"57","author":"LA Kamioka","year":"2023","unstructured":"Kamioka LA, et al. Seroprevalence of SARS-CoV-2 antibodies in schoolchildren in S\u00e3o Paulo, Brazil. Rev Saude Publica. 2023;57(Suppl 1):6s. https:\/\/doi.org\/10.11606\/s1518-8787.2023057004782.","journal-title":"Rev Saude Publica"},{"key":"13083_CR37","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1056\/NEJMoa2114228","volume":"385","author":"Y Goldberg","year":"2021","unstructured":"Goldberg Y, Mandel M, Bar-On YM, et al. Waning immunity after the BNT162b2 vaccine in Israel. N Engl J Med. 2021;385:e85. https:\/\/doi.org\/10.1056\/NEJMoa2114228.","journal-title":"N Engl J Med"},{"key":"13083_CR38","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1056\/NEJMoa2114583","volume":"385","author":"EG Levin","year":"2021","unstructured":"Levin EG, Lustig Y, Cohen C, et al. Waning humoral immune response to BNT162b2 vaccine over 6 months. N Engl J Med. 2021;385:e84. https:\/\/doi.org\/10.1056\/NEJMoa2114583.","journal-title":"N Engl J Med"},{"issue":"6529","key":"13083_CR39","doi-asserted-by":"publisher","first-page":"eabf4063","DOI":"10.1126\/science.abf4063","volume":"371","author":"JM Dan","year":"2021","unstructured":"Dan JM, Mateus J, Kato Y, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371(6529):eabf4063. https:\/\/doi.org\/10.1126\/science.abf4063.","journal-title":"Science"},{"issue":"58","key":"13083_CR40","doi-asserted-by":"publisher","first-page":"eabi6950","DOI":"10.1126\/sciimmunol.abi6950","volume":"6","author":"RR Goel","year":"2021","unstructured":"Goel RR, Apostolidis SA, Painter MM, et al. Distinct antibody and memory B cell responses in na\u00efve and recovered individuals following mRNA vaccination. Sci Immunol. 2021;6(58):eabi6950. https:\/\/doi.org\/10.1126\/sciimmunol.abi6950.","journal-title":"Sci Immunol"},{"key":"13083_CR41","doi-asserted-by":"publisher","first-page":"e78233","DOI":"10.7554\/eLife.78233","volume":"11","author":"CA Prete Jr","year":"2022","unstructured":"Prete CA Jr, Buss LF, Dighe A, et al. SARS-CoV-2 antibody dynamics in blood donors across eight Brazilian capitals. eLife. 2022;11:e78233. https:\/\/doi.org\/10.7554\/eLife.78233.","journal-title":"eLife"},{"key":"13083_CR42","doi-asserted-by":"publisher","first-page":"1032411","DOI":"10.3389\/fimmu.2022.1032411","volume":"13","author":"PR Costa","year":"2022","unstructured":"Costa PR, Correia CA, Marmorato MP, et al. Humoral and cellular immune responses to CoronaVac up to one year after vaccination. Front Immunol. 2022;13:1032411. https:\/\/doi.org\/10.3389\/fimmu.2022.1032411.","journal-title":"Front Immunol"},{"key":"13083_CR43","doi-asserted-by":"publisher","first-page":"100284","DOI":"10.1016\/j.lana.2022.100284","volume":"12","author":"F Fiorino","year":"2022","unstructured":"Fiorino F, et al. Effectiveness of CoronaVac in preventing COVID-19 in Uruguay. Lancet Reg Health Am. 2022;12:100284. https:\/\/doi.org\/10.1016\/j.lana.2022.100284.","journal-title":"Lancet Reg Health Am"},{"key":"13083_CR44","doi-asserted-by":"publisher","first-page":"100025","DOI":"10.1016\/j.lana.2021.100025","volume":"1","author":"MDT Hitchings","year":"2021","unstructured":"Hitchings MDT, Ranzani OT, Dorion M, et al. Effectiveness of CoronaVac among healthcare workers in Brazil. Lancet Reg Health Am. 2021;1:100025. https:\/\/doi.org\/10.1016\/j.lana.2021.100025.","journal-title":"Lancet Reg Health Am"},{"key":"13083_CR45","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12879-022-07418-y","volume":"22","author":"P Ssentongo","year":"2022","unstructured":"Ssentongo P, et al. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe disease: systematic review. BMC Infect Dis. 2022;22:439. https:\/\/doi.org\/10.1186\/s12879-022-07418-y.","journal-title":"BMC Infect Dis"},{"key":"13083_CR46","doi-asserted-by":"publisher","first-page":"100154","DOI":"10.1016\/j.lana.2021.100154","volume":"6","author":"T Cerqueira-Silva","year":"2022","unstructured":"Cerqueira-Silva T, et al. Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines. Lancet Reg Health Am. 2022;6:100154. https:\/\/doi.org\/10.1016\/j.lana.2021.100154.","journal-title":"Lancet Reg Health Am"},{"key":"13083_CR47","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12916-022-02353-w","volume":"20","author":"ES Paix\u00e3o","year":"2022","unstructured":"Paix\u00e3o ES, et al. CoronaVac vaccine effectiveness in pregnant women: test-negative study. BMC Med. 2022;20:146. https:\/\/doi.org\/10.1186\/s12916-022-02353-w.","journal-title":"BMC Med"},{"issue":"5","key":"13083_CR48","doi-asserted-by":"publisher","first-page":"e103856","DOI":"10.1016\/j.bjid.2024.103856","volume":"28","author":"EJA Luna","year":"2024","unstructured":"Luna EJA, et al. Effectiveness of CoronaVac in the prevention of COVID-19 in Brazil: test-negative study. Braz J Infect Dis. 2024;28(5):e103856. https:\/\/doi.org\/10.1016\/j.bjid.2024.103856.","journal-title":"Braz J Infect Dis"},{"issue":"39","key":"13083_CR49","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1016\/j.vaccine.2023.07.065","volume":"41","author":"HS Monteiro","year":"2023","unstructured":"Monteiro HS, et al. Impact of CoronaVac on COVID-19 outcomes in elderly adults. Vaccine. 2023;41(39):5742\u201351. https:\/\/doi.org\/10.1016\/j.vaccine.2023.07.065.","journal-title":"Vaccine"},{"key":"13083_CR50","doi-asserted-by":"publisher","first-page":"100045","DOI":"10.1016\/j.lana.2021.100045","volume":"1","author":"R Palacios","year":"2021","unstructured":"Palacios R, et al. Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals (PROFISCOV). Lancet Reg Health Am. 2021;1:100045. https:\/\/doi.org\/10.1016\/j.lana.2021.100045.","journal-title":"Lancet Reg Health Am"},{"issue":"2","key":"13083_CR51","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00281-018-0726-5","volume":"41","author":"S Fischinger","year":"2019","unstructured":"Fischinger S, Boudreau CM, Butler AL, Streeck H, Alter G. Sex differences in vaccine-induced humoral immunity. Semin Immunopathol. 2019;41(2):239\u201349. https:\/\/doi.org\/10.1007\/s00281-018-0726-5.","journal-title":"Semin Immunopathol"},{"key":"13083_CR52","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.1038\/s41467-020-19741-6","volume":"11","author":"H Peckham","year":"2020","unstructured":"Peckham H, de Gruijter NM, Raine C, et al. Male sex as a risk factor for death and ICU admission due to COVID-19. Nat Commun. 2020;11:6317. https:\/\/doi.org\/10.1038\/s41467-020-19741-6.","journal-title":"Nat Commun"},{"key":"13083_CR53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.exger.2017.10.024","volume":"105","author":"G Pawelec","year":"2018","unstructured":"Pawelec G. Age and immunity: what is immunosenescence? Exp Gerontol. 2018;105:4\u20139. https:\/\/doi.org\/10.1016\/j.exger.2017.10.024.","journal-title":"Exp Gerontol"},{"issue":"1","key":"13083_CR54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","volume":"19","author":"J Nikolich-\u017dugich","year":"2018","unstructured":"Nikolich-\u017dugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018;19(1):10\u20139. https:\/\/doi.org\/10.1038\/s41590-017-0006-x.","journal-title":"Nat Immunol"},{"key":"13083_CR55","doi-asserted-by":"publisher","first-page":"eabn4274","DOI":"10.1126\/sciadv.abn4274","volume":"8","author":"A Mukherjee","year":"2022","unstructured":"Mukherjee A, et al. Measuring vaccine effectiveness in resource-constrained settings. Sci Adv. 2022;8:eabn4274. https:\/\/doi.org\/10.1126\/sciadv.abn4274.","journal-title":"Sci Adv"},{"issue":"1","key":"13083_CR56","doi-asserted-by":"publisher","first-page":"e0261930","DOI":"10.1371\/journal.pone.0261930","volume":"17","author":"Y Teerawattananon","year":"2022","unstructured":"Teerawattananon Y, Anothaisintawee T, et al. Real-world effectiveness methodologies for COVID-19 vaccines: systematic review. PLoS ONE. 2022;17(1):e0261930. https:\/\/doi.org\/10.1371\/journal.pone.0261930.","journal-title":"PLoS ONE"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13083-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13083-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13083-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:24:29Z","timestamp":1776813869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13083-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13083"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13083-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was approved by the Ethics Committee of the Christus University Center (opinion n\n                      o\n                      . 4,997,175). All participants provided written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"802"}}